NCT05614427View on ClinicalTrials.gov

The LAVA (Lateral Flow Antigen Validation and Applicability) 2 Study for COVID-19

NACompletedINTERVENTIONAL
Enrollment

449

Participants

Timeline

Start Date

March 26, 2021

Primary Completion Date

December 20, 2021

Study Completion Date

April 20, 2022

Conditions
SARS-CoV-2 Infection
Interventions
DIAGNOSTIC_TEST

Innova Lateral Flow Test

Lateral flow test performed on anterior nasal or buccal swabs

Trial Locations (1)

Unknown

Alder Hey Children's NHS Foundation Trust, Liverpool

All Listed Sponsors
lead

Alder Hey Children's NHS Foundation Trust

OTHER

NCT05614427 - The LAVA (Lateral Flow Antigen Validation and Applicability) 2 Study for COVID-19 | Biotech Hunter | Biotech Hunter